NEOSTIGMINE METHYLSULFATE

longtime favorite with very few side effects

TO UNDO THE MUSCLE RELAXATION EFFECTS PRIOR TO DISCONTINUING ANESTHESIA

NEOSTIGMINE METHYLSULFATE (CAS 51-60-5) is a cholinesterase inhibitor that is mainly used as an injectable.

THERAPEUTIC GROUP: NERVOUS SYSTEM

NEOSTIGMINE METHYLSULFATE is indicated for reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs, like VECURONIUM or ROCURONIUM BROMIDE) after surgery.

Neostigmine is on the World Health Organization's model list of essential medicines.

MARKET INFORMATION

NEOSTIGMINE METHYLSULFATE has been used since the late 1930s with extensive clinical experience.

Brand names: BLOXIVERZ®, NAFCILLIN®, NEOSTIGMIN®, PROSTIGMINE®,  STIGNAL®, VAGOSTIGMIN®, VERSIA® et al.

YOUR ADVANTAGES   

  • Reliable partner with complete documentation for regulated markets
  • Full regulatory support
  • Short lead time
  • Also used to improve focus adjustment of the eye

This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.